+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mucosta"

Mucosta - API Insight, 2022 - Product Thumbnail Image

Mucosta - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Mucosta- Drug Insight, 2019 - Product Thumbnail Image

Mucosta- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Mucosta is a market within the context of Gastrointestinal Drugs, which are used to treat a variety of gastrointestinal disorders. These drugs are used to reduce inflammation, reduce pain, and improve digestion. Mucosta drugs are typically used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and other gastrointestinal disorders. They are available in both oral and topical forms, and can be used to treat both acute and chronic conditions. Mucosta drugs are typically prescribed by a physician, and are available in both over-the-counter and prescription forms. Common side effects of Mucosta drugs include nausea, vomiting, diarrhea, and abdominal pain. The Mucosta market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Pfizer, and Takeda. These companies offer a range of products, including oral medications, topical creams, and injectables. Show Less Read more